News in botulinum toxin therapy. From dystonia to prophylactic treatment of migraine;Neues in der botulinumtoxin-therapie. Von der dystonie bis zur migräneprophylaxe

Nervenheilkunde

Volumn 20, Issue 3, 2001, Pages 151-157

  Ceballos Baumann, A O ^a   Petri, S ^a   Toelle, T ^a   Heckmann, M ^a   Conrad, B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antibodies; Botulinum toxin; Dystonia; Hyperhidrosis; Migraine; Spasticity; Tension headache; Tremor

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; NEUTRALIZING ANTIBODY;

ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DYSTONIA; HUMAN; HYPERHIDROSIS; MIGRAINE; TENSION HEADACHE; TREATMENT PLANNING; TREMOR;

EID: 0035027991     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Long-term efficacy of Botulinum toxin in classical achalasia: A prospective study
2. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial
3. Intrasphincteric injection of botulinum toxin is effective in long-term treatment of esophageal achalasia
4. Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia
5. Severe constipation in Parkinson's disease relieved by botulinum toxin
6. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure
7. Botulinum toxin injections for voiding dysfunction following SCI
8. Treatment of vaginismus with botulinum toxin injections
9. Development of resistance to botulinum toxin type A in patients with torticollis
10. Long-term treatment of cervical dystonia with botulinum toxin A: Efficacy, safety, and antibody frequency
11. Botulinum A toxin therapy: Neutralizing and nonneutralizing antibodies-therapeutic consequences
12. Serum antibody production to botulinum A toxin
13. Change in pattern of muscle activity following botulinum toxin injections for torticollis
14. The edb test: A clinical test for the detection of antibodies to botulinum toxin type a
15. Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A
16. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A
17. BotB (botulinum toxin type B): Evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study)
18. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia
19. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia
20. Selective peripberal denervation for spasmodic torticollis: Is the outcome predictable?
21. Dystonien
22. What is the optimal close of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport
23. Botulinum toxin injections for essential voice tremor
24. Botulinum toxin treatment of essential head tremor
25. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor
26. Botulinum toxin A injections for the treatment of hand tremors
27. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor
28. Botulinum toxin in treating spasticity
29. Treatment of spasticity with botulinum toxin: A double-blind study
30. Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations
31. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients
32. Management of spasticity in cerebral palsy with botulinum-A toxin: Report of a preliminary, randomized, double-blind trial
33. Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms
34. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury
35. Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients
36. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients
37. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
38. Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients
39. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: A randomized, double-blind, placebo-controlled trial
40. Local injection treatment with botulinum toxin A in severe arm and leg spasticity
41. Botulinum toxin for spasticity and athetosis in children with cerebral palsy
42. The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy-a pilot study
43. Measurement of botulinum toxin activity: Evaluation of the lethality assay
44. Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study
45. Cosmetic therapy with botulinum toxin: Anecdotal memoirs
46. Therapie des fre-syndroms mit botulinum-toxin. Erfahrungen mit einer neuen behandlungsmethode
47. Double blind trial of botulinum a toxin for the treatment of focal hyperhidrosis of the palms
48. Botulinum toxin for palmar hyperhidrosis
49. Optimizing botulinum toxin a for hyperhidrosis
50. Botulinum toxin-A for axillary hyperhidrosis
51. Botulinum toxin A as treatment for drooling saliva in PD
52. Sialorrhea in amyotrophic lateral sclerosis: A hypothesis of a new treatment-botulinum toxin A injections of the parotid glands
53. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis
54. Treatment of drooling in Parkinson's disease with botulinum toxin
55. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin
56. Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients
57. Lokale injektionsbehandlung mit botulinum-toxin a bei blepharospasmus, meige syndrom und spasmus hemifacialis. Beobachtungen an 106 patienten
58. Management of spasticity associated pain with botulinum toxin A
59. Botulinum toxin in the treatment of myofascial pain syndrome
60. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome
61. Exteroceptive suppression of temporalis muscle activity: Perspectives in headache and pain research
62. Exteroceptive suppression of temporalis muscle activity in various types of headache
63. Tension-type headache: An update on mechanisms and treatment
64. Treatment of tension-type headache with botulinum toxin: A pilot study
65. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension
66. Tension headache: Botulinum toxin paralysis of temporal muscles
67. Treatment of tension-type headache with botulinum toxin type A: A double-blind, placebo-controlled study
68. Exteroceptive suppression of the masseter, temporalis and trapezius muscles produced by mental nerve stimulation in patients with chronic headaches
69. Botulinum toxin type A for migraine: An open label assesment
70. Botulinum Toxin Type A as a Migraine Preventive Treatment